← back to search

Samreen Ahmed

Aligarh Muslim University · IN
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Lung Cancer Treatments and Mutations, Advanced Breast Cancer Therapies, Lung Cancer Diagnosis and Treatment, and Breast Cancer Treatment Studies.
h-index
27
citations
3,601
works
122
NIH funding
primary concept
Medicine
email

Recent publications

Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
New England Journal of Medicine 2023cited by 627position: middledoi
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817
Journal for ImmunoTherapy of Cancer 2023cited by 69position: middledoi
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227
Journal of Clinical Oncology 2022cited by 369position: middledoi
Unsupervised Clustering Reveals Sarcoidosis Phenotypes Marked by a Reduction in Lymphocytes Relate to Increased Inflammatory Activity on 18FDG-PET/CT
Frontiers in Medicine 2021cited by 22position: middledoi
European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment
European Journal of Cancer 2020cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2020–2020)Judith Bushong · Bristol-Myers Squibb (United States)1 papers (2022–2022)Tudor–Eliade Ciuleanu · Iuliu Hațieganu University of Medicine and Pharmacy1 papers (2022–2022)Laura J. Eccles · Bristol-Myers Squibb (United States)1 papers (2022–2022)Clarisse Audigier-Valette · Université de Toulon1 papers (2022–2022)Adam Płużański · National Institute of Oncology1 papers (2022–2022)Dustin R. Fraidenburg · University of Illinois Chicago1 papers (2021–2021)Adam J. Schoenfeld · Hartford Financial Services (United States)1 papers (2022–2022)Hossein Borghaei · The Ohio State University1 papers (2022–2022)Igor Andrašina · Národný Onkologický Ústav1 papers (2023–2023)Noriko Yanagitani · The Cancer Institute Hospital1 papers (2023–2023) · 1 papers (2020–2020)Julie R. Brahmer · Bloomberg (United States)1 papers (2022–2022)Yuri Rukazenkov · AstraZeneca (United Kingdom)1 papers (2023–2023)Nikolaos Tsoukalas · National and Kapodistrian University of Athens1 papers (2020–2020)Christian Ascoli · University of Illinois Chicago1 papers (2021–2021)Gustav Ullenhag · Uppsala University1 papers (2020–2020)David Planchard · Institut Gustave Roussy1 papers (2023–2023)Mauricio Mahave · Samsung Medical Center1 papers (2022–2022)Kunihiko Kobayashi · National Cancer Center Hospital East1 papers (2023–2023)